Expert Consensus on the Diagnosis, Treatment, and Prevention of Respiratory Syncytial Virus Infections in Children
Xian-Li Zhang,Xi Zhang,Wang Hua,Zheng-De Xie,Han-Min Liu,Hai-Lin Zhang,Bi-Quan Chen,Yuan Chen,Xin Sun,Yi Xu,Sai-Nan Shu,Shun-Ying Zhao,Yun-Xiao Shang,Ling Cao,Yan-Hui Jia,Luo-Na Lin,Jiong Li,Chuang-Li Hao,Xiao-Yan Dong,Dao-Jiong Lin,Hong-Mei Xu,De-Yu Zhao,Mei Zeng,Zhi-Min Chen,Li-Su Huang
DOI: https://doi.org/10.1007/s12519-023-00777-9
2024-01-01
World Journal of Pediatrics
Abstract:BackgroundRespiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children.Data sourcesThe evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using variations in terms for "respiratory syncytial virus", "RSV", "lower respiratory tract infection", "bronchiolitis", "acute", "viral pneumonia", "neonatal", "infant" "children", and "pediatric".ResultsEvidence-based recommendations regarding diagnosis, treatment, and prevention were proposed with a high degree of consensus. Although supportive care remains the cornerstone for the management of RSV infections, new monoclonal antibodies, vaccines, drug therapies, and viral surveillance techniques are being rolled out.ConclusionsThis consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points.3Zrgg9eFrSMG87iwcWiBtJVideo Abstract (MP4 142103 KB)ConclusionsThis consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points.3Zrgg9eFrSMG87iwcWiBtJVideo Abstract (MP4 142103 KB)